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pler guidewire. Patients were divided into two groups based on myocardial viability
assessed by single-photon emission computed tomographic thallium-201 imaging 6
months after the infarction; 81 patients with viable myocardium and 32 patients with non-
viable myocardium. Redistribution patterns or residual maximal myocardial activity >50%
are indices of tissue viability.
Results: Coronary flow velocity variables showed significantly higher systolic peak veloc-
ity (8±20 vs -31±23 cm/s; p=0.0001) and longer DDT (722±196 vs 312±157 ms;
p=0.0001) in viable myocardial group compared with nonviable myocardial group. The
optimal cutoff values to predict viable myocardium was 0 cm/s for systolic peak velocity
and 600ms for DDT (sensitivity=0.85, specificity=0.94 and sensitivity=0.93, specific-
ity=0.91, respectively).
Conclusion: These data suggest that the CFV pattern is an accurate predictor of the
presence or absence of residual myocardial viability at the late stage in patients with
anterior AMI.
1157-48 Reduced Shear Stress and Large Shear Stress Gradient 
Cause Coronary Aneurysm and Thrombus Formation in 
Children With Kawasaki Disease
Ei Ikegami, Ryuji Fukazawa, Mituhiro Kamisago, Miharu Hajikano, Miki Watanabe, Yohko 
Uchikoba, Yasuhiro Katube, Shunichi Ogawa, Nippon Medical School, Tokyo, Japan
We tested whether reduced shear stress (SS) and large shear stress gradient could be
caused coronary artery aneurysm (AN) formation at coronary branching site and throm-
bus formation in AN in patients with Kawasaki disease (KD). 139 children (2y - 16y) who
had coronary abnormality revealed by 2-D echo were subjected. All patients had different
sized AN without any significant stenosis in proximal and distal portion of AN and were
divided into four groups by the maximum diameter of AN; Group S: < 1.5-fold the diame-
ter of the adjacent normal-looking vessel, n=34, Group M:1.5 </= to < 4.0-fold, n=31,
Group L: </= 4.0-hold, n=29, Group N: normal-looking vessels by CAG, n=45. All patients
had Aspirin and / or Warfarin. The averaged peak velocity (APV) was measured at the
middle of ANs in groups L, M and S, at the branching site of segment 5-6-11 in group N,
and at the normal-looking proximal lesion of AN in all 4 groups. SS was calculated by the
simplified formula as: shear stress = 4µAPV/(R/2), where µ is blood viscosity, R is maxi-
mum inner diameter of AN or coronary vessel. SS gradient was calculated by the formula
as: SS gradient = SS at normal-looking lesion / SS at AN or coronary branching site.
Also, CAG and IVUS were performed for detection of thrombus and localization of
ANs.Results:* p < 0.05 vs. groups M, S. SS in normal-looking vessels were 26.6 ± 3.1
Conclusions: Reduced shear stress and large shear stress gradient may play a critical
role of giant aneurysm and thrombus formation intra coronary aneurysms in Kawasaki
disease.
1157-49 Physiologic and Anatomical Evaluation Prior to and 
After Stent Implantation in Small Coronary Vessels: 
Final Results of PHANTOM Trial
Marco A. Costa, Manel Sabate, Rodolfo Staico, Fernando Alfonso, Paul Gilmore, Brett 
Sasseen, Martin Zenni, Seixas Ana Cristina, J Eduardo Sousa, Carlos Macaya, 
Theodore Bass, University of Florida Shands Jacksonville, Jacksonville, FL, Hospital 
Clinico San Carlos, Madrid, Spain
Background: Long-term outcomes after PCI of small coronary artery disease remain
suboptimal, but there is no diagnostic tool available to define (in)appropriateness of PCI
in this setting. This prospective multicenter study investigates the role of intravascular
ultrasound (IVUS), quantitative coronary angiography (QCA) and fractional flow reserve
(FFR) in patients with small coronary arteries.
Methods: Sixty patients with small coronary arteries (reference diameter <2.8mm) and
coronary stenoses between 40-70% were included. A 0.014-in pressure guide wire
(Wave Wire) was used for FFR measurements after 2 minutes of IV infusion of adenosine
(140 µg/kg/min). Volumetric 3D-IVUS and angiography data were analyzed in an inde-
pendent core laboratory. PCI was deferred if FFR >0.75. Optimal stenting was defined by
IVUS (minimal lumen area (MLA) instent >80% of reference MLA). Clinical follow-up was
scheduled at 6 and 12 months.
Results: Mean age was 62.4±10y, 40% had diabetes and 84% had HTN. There were no
procedure complications. Mean RD (reference diameter) was 2.1mm. Sixty percent of the
patients had normal FFR (<0.75). Seventy percent of patients with a CSA obstruction
>70% by IVUS had an FFR<0.75, while 100% with CSA obstruction >75% had FFR
<0.75. Angiographic MLD was not correlated with FFR. Forty-four percent had post-
stenting FFR<0.90 in spite of optimal IVUS result. Fifty six patients completed at least 6
month follow-up (25 completed 12-month). Among patients who did not undergo index
PCI because of an FFR<0.75 (n=27 out of 56 with follow-up), none required follow-up
revascularization. There were 5 repeat PCI in the cohort of patients initially treated with
PCI (n=23). Complete follow-up data will be presented. Conclusion: The majority of
intermediate lesions in small vessels may not require PCI. There is a poor correlation
between physiological and anatomical parameters in patients with small vessel disease.
Deferring PCI based on FFR>0.75 appears to be safe in patients moderate stenosis in
small coronary vessels. Considering the high incidence of restenosis, FFR represents a
valuable tool to define the appropriateness of PCI in small vessels.
1157-50 Hyperinsulinemia Is Associated With Coronary 
Endothelial Dysfunction in Obese and Nondiabetic 
Patients
Hideki Okui, Shuichi Hamasaki, Takashi Yoshitama, Sanemasa Ishida, Akiko Yoshikawa, 
Tetsuro Kataoka, Koji Orihara, Masakazu Ogawa, Tsuyoshi Fukudome, Naoya Oketani, 
Keishi Saihara, Takuro Shinsato, Shinichi Minagoe, Chuwa Tei, Kagoshima University, 
Kagoshima, Japan
Background: The American Heart Association (AHA) has recently classified obesity as a
modifiable risk factor for coronary heart disease. Therefore, we evaluated the impact of
obesity on insulin resistance and coronary endothelial function in overweight patients
with normal or mild coronary artery disease. Methods: A total of 32 consecutive non-dia-
betic patients with normal or mildly diseased coronary arteries at angiography underwent
coronary vascular reactivity evaluation using intracoronary administration of papaverine,
acetylcholine and nitroglycerin using a Doppler guidewire. Patients were divided into two
groups based on body mass index (BMI): Group 1, patients with a BMI<25 (n = 19, nor-
mal weight); and Group 2, patients with a BMI>25 (n = 13, overweight). The level of fast-
ing immunoreactive insulin (FIRI) and fasting blood glucose (FBS) were measured in
each subject. Homeostasis model assessment (HOMA-R) was used as an indicator of
insulin resistance. Results: FIRI and HOMA-R in Group 2 were significantly greater than
those in Group 1 (4.4±2.7 vs. 14.5±7.4 µU/ml, p<0.01; 1.02±0.62 vs. 3.52±1.77, p<0.01,
respectively), whereas FBS was similar when comparing the two groups (95±11 vs.
98±13 mg/dl). The percent change in coronary blood flow and coronary artery diameter
induced by acetylcholine in Group 2 had a significant negative correlation with both
HOMA-R and FIRI (HOMA-R:r=-0.69, p<0.01; r=-0.64, p<0.02,FIRI: r=-0.69, p<0.01; r=-
0.72, p<0.01,respectively) but displayed no significant correlation in Group 1. Conclu-
sions: Obesity with hyperinsulinemia caused by increased insulin resistance is associ-
ated with coronary endothelial dysfunction in non-diabetic patients.
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1158-51 A Novel Antirestenosis Effect of Paclitaxel-Eluting 
Stents
Arturo G. Touchard, Mark Ungs, Bradley Poff, James Barry, Mary E. Russell, Greg 
Wilson, Robert S. Schwartz, Minnesota Cardiovascular Research Institute, Minneapolis, 
MN, Minneapolis Heart Institute, Minneapolis, MN
Background: Coronary stenting is a known, potent stimulator of adventitial angiogene-
sis.These post stent angiogenesis may help neointimal growth and maintenance. Cell
migration and proliferation blockage are two known mechanism of Paclitaxel limiting
neointimal hiperplasia. Paclitaxel is a known angiogenesis inhibitor in other tissues, like
tumors, nonentheless this effect on coronary arteries has not been yet studied. We thus
examined adventitial neovascularization in porcine coronary arteries following paclitaxel
eluting stent implant and compared them with control stents.
Methods: Forty-three stented arteries, 26 paclitaxel stents (1ug/mm2) and 17 controls
were examined blindly. Adventitial vessels (vasa vasorum) were identified as arterial
structures with endothelial cells surrounding a lumen, with or without erythrocytes.
Adventitial vessel density was determined by manual counting using a curved geometric
shape 400x50 microns placed in the adventitia, bordering the external elastic lamina. Inti-
mal thickness was measured from the back of each strut to the lumen and calculated an
average for each artery.
Results: Paclitaxel-stented arteries showed a marked decrease in adventitial vessels
compared with control stented vessels (1.5+1.2 versus 3.1 + 2.2 vessels/20,000 sq
microns, p<0.003). There was no statistical difference in minimum intima thickness
between the treated and control groups in this mild injury model (paclitaxel: 308.9 + 57.3,
controls: 284.9 + 59.0 microns, p>0.5).
Conclusions: Paclitaxel elution from stents is associated with markedly decreased
adventitial angiogenesis. In addition to its anti migratory and antiproliferative effects,
paclitaxel may prevent neointimal growth by preventing adventitial vasa vasorum, limiting
oxygen and nutrient supply to the neointima. If true, this opens novel therapeutic strate-
gies for limiting neointimal hyperplasia.
1158-52 Proteomic Profiling of Restenotic Lesions Unveils 
Increased Expression of Structural Proteins That Are 
Inhibited by Intramural Delivery of Rapamycin 
Ute Buerke, Markus Guckenbiehl, Ursula Müller-Werdan, Karl Werdan, Michael Buerke, 
Johannes Gutenberg University, Halle, Germany
Restenosis is the major limiting factor of balloon angioplasty.Identifying genes that regu-
late neointima formation is ongoing, facilitated by cDNA array profiling of the arterial wall.
This study utilizes proteomic profiling to identify gene products involved in arterial remod-
eling that occurs as a consequence of restenosis. We specifically identified proteins
inhibited by rapamycin since this drug is being used clinically for its anti-restenotic prop-
erties.
Intramural infusion of rapamycin or its vehicle was delivered through a balloon catheter
directly into the vessel wall during angioplasty. After 3 weeks, proteomic profiles of arte-
rial wall segments were obtained. On average, 485 protein spots were consistently
SS in AN or branching site SS gradient thrombus
L 6.8+/-3.3* 4.1+/-1.1* 24/29*
M 21.8+/-5.3 1.2+/-0.5 2/31
S 25.6+/-4.6 1.1+/-0.4 0/34
N 9.7+/-2.9* 3.0+/-1.5* 0/45
